anyaivanova/iStock via Getty Images
Great Growth, Bound To Slow
Thermo Fisher Scientific (TMO) recently released 2Q 2021 results showing 34% revenue growth and 44% non-GAAP EPS growth over 2Q 2020. This strong growth was largely due to non-COVID revenue…

Click here to view the original article.